289 related articles for article (PubMed ID: 16183084)
1. The substituted aspartate analogue L-beta-threo-benzyl-aspartate preferentially inhibits the neuronal excitatory amino acid transporter EAAT3.
Esslinger CS; Agarwal S; Gerdes J; Wilson PA; Davis ES; Awes AN; O'Brien E; Mavencamp T; Koch HP; Poulsen DJ; Rhoderick JF; Chamberlin AR; Kavanaugh MP; Bridges RJ
Neuropharmacology; 2005 Nov; 49(6):850-61. PubMed ID: 16183084
[TBL] [Abstract][Full Text] [Related]
2. Characterization of novel L-threo-beta-benzyloxyaspartate derivatives, potent blockers of the glutamate transporters.
Shimamoto K; Sakai R; Takaoka K; Yumoto N; Nakajima T; Amara SG; Shigeri Y
Mol Pharmacol; 2004 Apr; 65(4):1008-15. PubMed ID: 15044631
[TBL] [Abstract][Full Text] [Related]
3. The glutamate transporters EAAT2 and EAAT3 mediate cysteine uptake in cortical neuron cultures.
Chen Y; Swanson RA
J Neurochem; 2003 Mar; 84(6):1332-9. PubMed ID: 12614333
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological characterization of threo-3-methylglutamic acid with excitatory amino acid transporters in native and recombinant systems.
Eliasof S; McIlvain HB; Petroski RE; Foster AC; Dunlop J
J Neurochem; 2001 Apr; 77(2):550-7. PubMed ID: 11299317
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological characterization of human excitatory amino acid transporters EAAT1, EAAT2 and EAAT3 in a fluorescence-based membrane potential assay.
Jensen AA; Bräuner-Osborne H
Biochem Pharmacol; 2004 Jun; 67(11):2115-27. PubMed ID: 15135308
[TBL] [Abstract][Full Text] [Related]
6. DL-threo-beta-benzyloxyaspartate, a potent blocker of excitatory amino acid transporters.
Shimamoto K; Lebrun B; Yasuda-Kamatani Y; Sakaitani M; Shigeri Y; Yumoto N; Nakajima T
Mol Pharmacol; 1998 Feb; 53(2):195-201. PubMed ID: 9463476
[TBL] [Abstract][Full Text] [Related]
7. Chemoenzymatic Synthesis and Pharmacological Characterization of Functionalized Aspartate Analogues As Novel Excitatory Amino Acid Transporter Inhibitors.
Fu H; Zhang J; Tepper PG; Bunch L; Jensen AA; Poelarends GJ
J Med Chem; 2018 Sep; 61(17):7741-7753. PubMed ID: 30011368
[TBL] [Abstract][Full Text] [Related]
8. Caveolin-1 Sensitivity of Excitatory Amino Acid Transporters EAAT1, EAAT2, EAAT3, and EAAT4.
Abousaab A; Warsi J; Elvira B; Lang F
J Membr Biol; 2016 Jun; 249(3):239-49. PubMed ID: 26690923
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and preliminary pharmacological evaluation of novel derivatives of L-beta-threo-benzylaspartate as inhibitors of the neuronal glutamate transporter EAAT3.
Mavencamp TL; Rhoderick JF; Bridges RJ; Esslinger CS
Bioorg Med Chem; 2008 Aug; 16(16):7740-8. PubMed ID: 18650095
[TBL] [Abstract][Full Text] [Related]
10. β-Sulfonamido Functionalized Aspartate Analogues as Excitatory Amino Acid Transporter Inhibitors: Distinct Subtype Selectivity Profiles Arising from Subtle Structural Differences.
Hansen JC; Bjørn-Yoshimoto WE; Bisballe N; Nielsen B; Jensen AA; Bunch L
J Med Chem; 2016 Oct; 59(19):8771-8786. PubMed ID: 27636002
[TBL] [Abstract][Full Text] [Related]
11. Effects of threo-beta-hydroxyaspartate derivatives on excitatory amino acid transporters (EAAT4 and EAAT5).
Shigeri Y; Shimamoto K; Yasuda-Kamatani Y; Seal RP; Yumoto N; Nakajima T; Amara SG
J Neurochem; 2001 Oct; 79(2):297-302. PubMed ID: 11677257
[TBL] [Abstract][Full Text] [Related]
12. Differentiation of substrate and nonsubstrate inhibitors of the high-affinity, sodium-dependent glutamate transporters.
Koch HP; Kavanaugh MP; Esslinger CS; Zerangue N; Humphrey JM; Amara SG; Chamberlin AR; Bridges RJ
Mol Pharmacol; 1999 Dec; 56(6):1095-104. PubMed ID: 10570036
[TBL] [Abstract][Full Text] [Related]
13. Expression of GFP-tagged neuronal glutamate transporters in cerebellar Purkinje neurons.
Meera P; Dodson PD; Karakossian MH; Otis TS
Neuropharmacology; 2005 Nov; 49(6):883-9. PubMed ID: 16212990
[TBL] [Abstract][Full Text] [Related]
14. Photoswitchable Inhibitor of a Glutamate Transporter.
Cheng B; Shchepakin D; Kavanaugh MP; Trauner D
ACS Chem Neurosci; 2017 Aug; 8(8):1668-1672. PubMed ID: 28414419
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the tritium-labeled analog of L-threo-beta-benzyloxyaspartate binding to glutamate transporters.
Shimamoto K; Otsubo Y; Shigeri Y; Yasuda-Kamatani Y; Satoh M; Kaneko S; Nakagawa T
Mol Pharmacol; 2007 Jan; 71(1):294-302. PubMed ID: 17047096
[TBL] [Abstract][Full Text] [Related]
16. Properties of excitatory amino acid transport in the human U373 astrocytoma cell line.
Dunlop J; Lou Z; McIlvain HB
Brain Res; 1999 Aug; 839(2):235-42. PubMed ID: 10519046
[TBL] [Abstract][Full Text] [Related]
17. Retinal bipolar cell input mechanisms in giant danio. II. Patch-clamp analysis of on bipolar cells.
Wong KY; Cohen ED; Dowling JE
J Neurophysiol; 2005 Jan; 93(1):94-107. PubMed ID: 15229214
[TBL] [Abstract][Full Text] [Related]
18. Interaction of Excitatory Amino Acid Transporters 1 - 3 (EAAT1, EAAT2, EAAT3) with N-Carbamoylglutamate and N-Acetylglutamate.
Burckhardt BC; Burckhardt G
Cell Physiol Biochem; 2017; 43(5):1907-1916. PubMed ID: 29055942
[TBL] [Abstract][Full Text] [Related]
19. WAY-855 (3-amino-tricyclo[2.2.1.02.6]heptane-1,3-dicarboxylic acid): a novel, EAAT2-preferring, nonsubstrate inhibitor of high-affinity glutamate uptake.
Dunlop J; Eliasof S; Stack G; McIlvain HB; Greenfield A; Kowal D; Petroski R; Carrick T
Br J Pharmacol; 2003 Nov; 140(5):839-46. PubMed ID: 14517179
[TBL] [Abstract][Full Text] [Related]
20. The 'glial' glutamate transporter, EAAT2 (Glt-1) accounts for high affinity glutamate uptake into adult rodent nerve endings.
Suchak SK; Baloyianni NV; Perkinton MS; Williams RJ; Meldrum BS; Rattray M
J Neurochem; 2003 Feb; 84(3):522-32. PubMed ID: 12558972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
